Showing results (181-190 of 251) with videos related to

Sort By:
Pageof 26
Inflammatory Bowel Diseases|February 23, 2013
Factors that affect adherence to surveillance colonoscopy in patients with inflammatory bowel diseaseSonia Friedman, Adam S Cheifetz, Francis A Farraye, et al.
Journal of Crohn'S & Colitis|October 27, 2022
A Systematic Review on the Interest of Drug-tolerant Assay in the Monitoring of Inflammatory Bowel DiseaseMathilde Barrau, Manon Duprat, Pauline Veyrard, et al.
Inflammatory Bowel Diseases|June 12, 2019
Proactive Vs Reactive Therapeutic Drug Monitoring of Infliximab in Crohn's Disease: A Cost-Effectiveness Analysis in a Simulated CohortDiana M Negoescu, Eva A Enns, Brooke Swanhorst, et al.
Inflammatory Bowel Diseases|November 5, 2013
Lectin-reactive anti-α-gal in patients with Crohn's disease: correlation with clinical phenotypesParham Safaie, Maggie Ham, Peter Kuang, et al.
Inflammatory Bowel Diseases|July 18, 2014
High self-efficacy predicts adherence to surveillance colonoscopy in inflammatory bowel diseaseSonia Friedman, Adam S Cheifetz, Francis A Farraye, et al.
Journal of Crohn'S & Colitis|March 18, 2019
The Impact of Raising the Bar for Clinical Trials in Ulcerative ColitisBruce E Sands, Adam S Cheifetz, Chudy I Nduaka, et al.
Journal of Clinical Medicine|December 10, 2021
Therapeutic Drug Monitoring of Biologics in IBD: Essentials for the Surgical PatientRodrigo Bremer Nones, Phillip R Fleshner, Natalia Sousa Freitas Queiroz, et al.
Inflammatory Bowel Diseases|February 27, 2020
Identifying IBD Providers' Knowledge Gaps Using a Prospective Web-based SurveyLisa Malter, Animesh Jain, Benjamin L Cohen, et al.
The American Journal of Gastroenterology|November 26, 2024
Small-Molecule Neutrophil Modulator ADS051 is Safe and Well-Tolerated in a Phase 1 Single Ascending Dose StudyAdam S Cheifetz, Jessica R Allegretti, Megan Quintas, et al.
Igie : Innovation, Investigation and Insights|July 3, 2026
Artificial intelligence detection of endoscopic moderate-to-severe ulcerative colitis: a novel tool to enhance clinical trial recruitmentLaurie B Grossberg, Grace Geeganage, Aditya Mithal, et al.
Pageof 26